Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cells

Cancer Letters

Volumn 352, Issue 2, 2014, Pages 220-227

  Ryu, Hoon ^a   Oh, Ji Eun ^a   Rhee, Ki Jong ^b   Baik, Soon Koo ^a   Kim, Jiye ^a   Kang, Seong Joon ^a   Sohn, Joon Hyung ^a   Choi, Eunhee ^a   Shin, Ha Cheol ^c   Kim, Yong Man ^c   Kim, Hyun Soo ^c   Bae, Keum Seok ^a   Eom, Young Woo ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Pharmicell Co Ltd   (South Korea)

Author keywords

Adipose tissue derived stem cells; Growth suppression; High density culture; IFN ; MCF 7

Indexed keywords

BETA INTERFERON; BETA INTERFERON ANTIBODY; GLUCOSE; INTERFERON ANTIBODY; JANUS KINASE 1 INHIBITOR; JANUS KINASE 2 INHIBITOR; JANUS KINASE INHIBITOR; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ADULT; ARTICLE; CANCER INHIBITION; CELL DENSITY; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STEM CELL CULTURE;

ADIPOSE TISSUE-DERIVED STEM CELLS; GROWTH SUPPRESSION; HIGH DENSITY CULTURE; IFN-Β; MCF-7;

ADIPOSE TISSUE; ADULT; BREAST NEOPLASMS; CELL COUNT; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; GLUCOSE; HUMANS; INTERFERON-BETA; JANUS KINASE 1; JANUS KINASE 2; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; YOUNG ADULT;

EID: 84906059145     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.06.018     Document Type: Article

References (31)

1. Barzilay R., Melamed E., Offen D. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem cells 2009, 27:2509-2515.
2. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
3. Musina R.A., Bekchanova E.S., Belyavskii A.V., Sukhikh G.T. Differentiation potential of mesenchymal stem cells of different origin. Bull. Exp. Biol. Med. 2006, 141:147-151.
4. Sato Y., Araki H., Kato J., Nakamura K., Kawano Y., Kobune M., Sato T., Miyanishi K., Takayama T., Takahashi M., Takimoto R., Iyama S., Matsunaga T., Ohtani S., Matsuura A., Hamada H., Niitsu Y. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
5. Tang D.Q., Cao L.Z., Burkhardt B.R., Xia C.Q., Litherland S.A., Atkinson M.A., Yang L.J. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004, 53:1721-1732.
6. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
7. Klopp A.H., Gupta A., Spaeth E., Andreeff M., Marini F. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells 2011, 29:11-19.
8. Khakoo A.Y., Pati S., Anderson S.A., Reid W., Elshal M.F., Rovira, Nguyen A.T., Malide D., Combs C.A., Hall G., Zhang J., Raffeld M., Rogers T.B., Stetler-Stevenson W., Frank J.A., Reitz M., Finkel T. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 2006, 203:1235-1247.
9. Qiao L., Xu Z., Zhao T., Zhao Z., Shi M., Zhao R.C., Ye L., Zhang X. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008, 18:500-507.
10. Qiao L., Xu Z.L., Zhao T.J., Ye L.H., Zhang X.D. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett. 2008, 269:67-77.
11. Zhu Y., Sun Z., Han Q., Liao L., Wang J., Bian C., Li J., Yan X., Liu Y., Shao C., Zhao R.C. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009, 23:925-933.
12. Cousin B., Ravet E., Poglio S., De Toni F., Bertuzzi M., Lulka H., Touil I., Andre M., Grolleau J.L., Peron J.M., Chavoin J.P., Bourin P., Penicaud L., Casteilla L., Buscail L., Cordelier P. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE 2009, 4:e6278.
13. Dasari V.R., Kaur K., Velpula K.K., Gujrati M., Fassett D., Klopfenstein J.D., Dinh D.H., Rao J.S. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS ONE 2010, 5:e10350.
14. Dasari V.R., Velpula K.K., Kaur K., Fassett D., Klopfenstein J.D., Dinh D.H., Gujrati M., Rao J.S. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS ONE 2010, 5:e11813.
15. Otsu K., Das S., Houser S.D., Quadri S.K., Bhattacharya S., Bhattacharya J. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood 2009, 113:4197-4205.
16. Sottini A., Capra R., Serana F., Chiarini M., Caimi L., Imberti L. Interferon-beta therapy monitoring in multiple sclerosis patients. Endocr. Metab. Immune Disord. Drug Targets 2009, 9:14-28.
17. Matsuzuka T., Miller K., Pickel L., Doi C., Ayuzawa R., Tamura M. The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines. Mol. Cell. Biochem. 2009, 320:163-171.
18. Dezawa M., Ishikawa H., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., Ide C., Nabeshima Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005, 309:314-317.
19. Eom Y.W., Lee J.E., Yang M.S., Jang I.K., Kim H.E., Lee D.H., Kim Y.J., Park W.J., Kong J.H., Shim K.Y., Lee J.I., Kim H.S. Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts. Biochem. Biophys. Res. Commun. 2011, 408:167-173.
20. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 1998, 238:265-272.
21. Schneider P.R., Buhrmann C., Mobasheri A., Matis U., Shakibaei M. Three-dimensional high-density co-culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells. J. Orthop. Res. 2011, 29:1351-1360.
22. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
23. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
24. Ambjorn M., Ejlerskov P., Liu Y., Lees M., Jaattela M., Issazadeh-Navikas S. IFNB1/interferon-beta-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function. Autophagy 2013, 9:287-302.
25. Huang H., Xiao T., He L., Ji H., Liu X.Y. Interferon-beta-armed oncolytic adenovirus induces both apoptosis and necroptosis in cancer cells. Acta Biochim. Biophys. Sin. 2012, 44:737-745.
26. Qin X.Q., Beckham C., Brown J.L., Lukashev M., Barsoum J. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models. Mol. Ther.: J. Am. Soc. Gene Ther. 2001, 4:356-364.
27. Shimizu M., Akiyama S., Ito K., Kasai Y., Takagi H., Kito M., Ohishi N., Yagi K. Effect on colon cancer cells of human interferon-beta gene entrapped in cationic multilamellar liposomes. Biochem. Mol. Biol. Int. 1998, 44:1235-1243.
28. Dickson P.V., Hamner J.B., Burger R.A., Garcia E., Ouma A.A., Kim S.U., Ng C.Y., Gray J.T., Aboody K.S., Danks M.K., Davidoff A.M. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma. J. Pediatr. Surg. 2007, 42:48-53.
29. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005, 65:3307-3318.
30. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002, 62:3603-3608.
31. Aboody K.S., Najbauer J., Danks M.K. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 2008, 15:739-752.